Navigation Links
AVACEN Medical Patent Issued
Date:7/1/2015

SAN DIEGO, July 1, 2015 /PRNewswire/ -- AVACEN, Inc. announced today the issue by the US Patent Office of a second AVACEN patent covering the medical technology platform supporting its unique Dry Heat Therapy AVACEN 100 product.

Logo - http://photos.prnewswire.com/prnh/20150630/227364LOGO

The apparatus and methods patent no. 9,066,781 - Methods And Apparatus For Therapeutic Application of Thermal Energy shields certain medical devices manufactured by AVACEN and specific methods of use, referred to by the company as the AVACEN Treatment Method.

The patent consists of 20 claims related to innovations introduced in AVACEN's medical technology that allow multiple therapeutic uses to alleviate a symptom associated with a circulatory, neurological, lymphatic, or endocrinal dysfunction, or any combination thereof.

"This further protects AVACEN's multi-million dollar investment in developing the AVACEN Treatment Method and our first commercial product, the AVACEN 100, which is designed for sufferers of pain related to arthritis and fibromyalgia*," said Thomas G. Muehlbauer, Chairman and CEO, AVACEN Medical.

In January of 2015 AVACEN Medical filed a De Novo application with the FDA to approve its marketing of the AVACEN 100 to sufferers of fibromyalgia.

Fibromyalgia is a complex chronic pain disorder that affects an estimated 10 million Americans. For those with severe symptoms, fibromyalgia can be extremely debilitating and interfere with basic daily activities. "Patent approvals of the AVACEN Treatment Method along with our encouraging Fibromyalgia Clinical Study and anecdotal results are giant steps forward when it comes to commercializing our intellectual property to relieve the pain associated with this terrible disease," added Mr. Muehlbauer.

About the AVACEN 100: In March of 2014 the US Patent Office issued Patent No. 8,679,170 to AVACEN covering key aspects of their medical technology platform and in August of 2014 the FDA cleared the AVACEN 100 as a Class II medical device for the temporary relief of joint pain associated with arthritis; muscle spasms; minor strains and sprains; and muscular relaxation.

About AVACEN: AVACEN Medical is dedicated to the innovation and design of safe, easy to use, noninvasive drug free alternatives to treat pain associated with diseases such as arthritis, fibromyalgia and migraines.

Contact: Ryan Jeffcoat at (888) 4-AVACEN x 711 or Email.

* The AVACEN 100 is pending approval for widespread pain related to fibromyalgia at the U.S. FDA and is not available for sale in the U.S. or globally for that indication.


'/>"/>
SOURCE AVACEN, Inc.
Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. AVACEN Medical Announces FDA Clearance of First Medical Device with Internal Game Mode
2. Vasomedical Announces Financial Results for the First Quarter of 2013
3. CCS Medical Moves Forward as Medicare Winner
4. PENTAX Medical Launches Industrys Highest* Resolution HD+ Imaging Technology For Flexible Endoscopy
5. SOAPware President Randall Oates, M.D. Among First NCQA Certified Patient-Centered Medical Home Content Experts
6. RAD Technology Medical Systems Delivers Innovative Time Saving Modular Construction At New Swedish Cancer Institute Facility
7. PENTAX Medical And Hitachi-Aloka Medical Continue Joint Innovation And Global Leadership In Endoscopic Ultrasound Systems
8. ACLS Online Course Manuals are Now Available at No Cost through United Medical Education
9. Statistical Challenges in Medical Device Trail Evaluation
10. Claret Medical, Inc. Announces Publication of the First Clinical Research on the Frequency and Composition of Embolic Debris Captured during TAVR
11. Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2018)... ... September 14, 2018 , ... Harris Teeter announced ... affected by Hurricane Florence. , Throughout the month of September, the company invites ... or round up their transaction to the nearest dollar to help support the ...
(Date:9/13/2018)... ... September 13, 2018 , ... This September is Centers ... is designed to raise awareness on how to help prevent food poisoning. According to ... get sick, 128,000 are hospitalized, and 3,000 die from eating contaminated food. In support ...
(Date:9/13/2018)... (PRWEB) , ... September 13, 2018 , ... ... is now available to test and ensure correct implementation of the NCPDP ... SCRIPT Version 2017071 includes important functionality and transactions identified by the industry as ...
Breaking Medicine Technology:
(Date:9/1/2018)... ... ... SignatureCare Emergency Center is looking to award their 2018 Fall Scholarship. The $1000 ... your applications in now as the deadline is approaching fast. (July 31) , SignatureCare ... student at Texas Southern University. Wu was inspired to go into the medical field ...
(Date:8/31/2018)... ... 31, 2018 , ... MedMark Treatment Centers Kentwood, a BayMark ... from 1:00-3:00 pm. MedMark invites the community to explore the world ... meet our staff and learn more about medication-assisted treatment services. MedMark Kentwood can ...
(Date:8/31/2018)... (PRWEB) , ... August 31, 2018 , ... Nitro Circus ... SeaLegs at the Beach – an action sports gathering to celebrate the life of ... The event raised money for Erik’s wife, Annika and their two small children, Oskar ...
(Date:8/31/2018)... ... 2018 , ... ZPower, the world’s only developer of rechargeable, ... Information Officer. Arneja previously served as Director of Information Systems and in his ... scale, and innovate the business. , Prior to joining ZPower, Arneja gained ...
(Date:8/29/2018)... ... August 29, 2018 , ... ... socialize or communicate with others. Physically, it is not possible to identify people ... problems may be challenged. People with autism may need assistance in developing skills, ...
Breaking Medicine News(10 mins):